US2002147209A1PendingUtilityA1
Cycloalkano-indole and -azaindole derivatives
Priority: Oct 4, 1994Filed: Dec 11, 2000Published: Oct 10, 2002
Est. expiryOct 4, 2014(expired)· nominal 20-yr term from priority
Inventors:Ulrich MullerRichard ConnellSiegfried GoldmannRudi GrutzmannMartin BeuckHilmar BischoffDirk DenzerAnke Domdey-BetteStefan Wohlfeil
A61P 9/04A61P 9/00A61P 3/04A61P 9/08A61P 9/10A61P 3/06C07D 219/02A61P 1/00A61P 1/18C07D 471/04A61P 1/10
52
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
Cycloalkano-indole and -azaindole derivatives are prepared by reaction of appropriately substituted carboxylic acids with amines. The cycloalkano-indole and -azaindole derivatives are suitable as active compounds for medicaments, preferably antiatherosclerotic medicaments.
Claims
exact text as granted — not AI-modified1 . Cycloalkano-indole and -azaindole derivatives of the general formula (I)
in which
R 1 and R 2 , including the double bond connecting them, together form a phenyl or pyridyl ring or a ring of the formula
wherein R 8 denotes hydrogen or straight-chain or branched alkyl having up to 4 carbon atoms,
R 3 and R 4 , including the double bond connecting them, together form a phenyl ring or a 4- to 8-membered cycloalkene or oxocycloalkene radical,
or ring systems mentioned under R 1 /R 2 and R 3 /R 4 optionally being substituted up to 3 times by identical or different halogen trifluoromethyl, carboxyl or hydroxyl substituents, by straight-chain or branched alkoxy or alkoxycarbonyl each having up to 6 carbon atoms or by straight-chain or branched alkyl having up to 6 carbon atoms, which, for its part, can be substituted by hydroxyl or by straight-chain or branched alkoxy having up to 4 carbon atoms,
D represents hydrogen, cycloalkyl having 4 to 12 carbon atoms or straight-chain or branched alkyl having up to 12 carbon atoms,
E represents the —CO— or —CS— group,
L represents an oxygen or sulphur atom or a group of the formula —NR 9 ,
wherein
R 9 denotes hydrogen or straight-chain or branched alkyl having up to 6 carbon atoms, which is optionally substituted by hydroxyl or phenyl,
R 5 represents phenyl or a 5- to 7-membered saturated or unsaturated heterocycle having up to 3 heteroatoms from the series consisting of S, N and/or O,
the cycles optionally being substituted up to 3 times by identical or different nitro, carboxyl, halogen or cyano substituents or by straight-chain or branched alkenyl or alkoxycarbonyl each having up to 6 carbon atoms or by straight-chain or branched alkyl having up to 6 carbon atoms, which is optionally substituted by hydroxyl, carboxyl or by straight-chain or branched alkoxy or alkoxycarbonyl each having up to 6 carbon atoms,
and/or the cycles optionally being substituted by a group of the formula —OR 10 or —NR 11 R 12 ,
wherein
R 10 denotes hydrogen or straight-chain or branched alkyl or alkenyl each having up to 6 carbon atoms,
R 11 and R 12 are identical or different and denote phenyl, hydrogen or straight-chain or branched alkyl having up to 6 carbon atoms or straight-chain or branched acyl having up to 8 carbon atoms, which is optionally substituted by a group of the formula —NR 13 R 14 ,
wherein
R 13 and R 14 are identical or different and denote hydrogen or straight-chain or branched acyl having up to 8 carbon atoms,
R 6 represents hydrogen, carboxyl or straight-chain or branched alkoxycarbonyl having up to 5 carbon atoms, or represents straight-chain or branched alkyl having up to 6 carbon atoms, which is optionally substituted by hydroxyl or by a group of the formula —O—CO—R 15 ,
wherein
R 15 denotes phenyl which is optionally substituted up to 3 times by identical or different halogen or hydroxyl substituents or by straight-chain or branched alkyl having up to 5 carbon atoms, or straight-chain or branched alkyl or alkenyl each having up to 22 carbon atoms, each of which is optionally substituted by a group of the formula —OR 6 ,
wherein
R 16 is hydrogen, benzyl, triphenylmethyl or straight-chain or branched acyl having up to 6 carbon atoms,
R 7 represents hydrogen or
R 6 and R 7 together represent the group of the formula ═O,
if appropriate in an isomeric form, and their salts.
2 . Cycloalkano-indole and -azaindole derivatives of the formula according to claim 1
wherein
R 1 and R 2 , including the double bond connecting them, together form a phenyl or pyridyl ring or a ring of the formula
wherein R 8 denotes hydrogen or straight-chain or branched alkyl having up to 3 carbon atoms,
R 3 and R 4 , including the double bond connecting them, together form a phenyl ring or a cyclopentene, cyclohexene, cycloheptene, cyclooctene, oxocyclopentene, oxocyclohexene, oxocycloheptene or oxocyclooctene radical,
or ring systems mentioned under R 1 /R 2 and R 3 /R 4 optionally being substituted up to 2 times by identical or different fluorine, chlorine, bromine, trifluoromethyl, carboxyl or hydroxyl substituents, by straight-chain or branched alkoxy or alkoxycarbonyl each having up to 4 carbon atoms or by straight-chain or branched alkyl having up to 4 carbon atoms, which, in turn, can be substituted by hydroxyl or by straight-chain or branched alkoxy having up to 3 carbon atoms,
D represents hydrogen, cyclobutyl, cyclopentyl, cyclohexyl, cycloheptyl, cyclooctyl or straight-chain or branched alkyl having up to 10 carbon atoms,
E represents the —CO— or —CS— group,
L represents an oxygen or sulphur atom or represents a group of the formula —NR 9 ,
wherein
R 9 denotes hydrogen or straight-chain or branched alkyl having up to 5 carbon atoms, which is optionally substituted by hydroxyl or phenyl,
R 5 represents phenyl, pyridyl, furyl, thienyl or imidazolyl, each of which is optionally substituted up to 2 times by identical or different nitro, carboxyl, fluorine, chlorine, bromine or cyano substituents, by straight-chain or branched alkenyl or alkoxy carbonyl each having up to 4 carbon atoms or by straight-chain or branched alkyl having up to 5 carbon atoms, which is optionally substituted by hydroxyl, carboxyl or by straight-chain or branched alkoxy or alkoxycarbonyl each having up to 5 carbon atoms,
and/or the cycles are optionally substituted by a group of the formula —OR 10 or —NR 11 R 12 ,
wherein
R 10 denotes hydrogen or straight-chain or branched alkyl or alkenyl each having up to 4 carbon atoms,
R 11 and R 12 are identical or different and denote phenyl, hydrogen or straight-chain or branched alkyl having up to 5 carbon atoms or denote straight-chain or branched acyl having up to 6 carbon atoms, which is optionally substituted by a group of the formula —NR 13 R 14 ,
wherein
R 13 and R 14 are identical or different and denote hydrogen or straight-chain or branched acyl having up to 6 carbon atoms,
R 6 represents hydrogen, carboxyl or straight-chain or branched alkoxycarbonyl having up to 4 carbon atoms, or represents straight-chain or branched alkyl having up to 5 carbon atoms, which is optionally substituted by hydroxyl or by a group of the formula —O—CO—R 5 ,
wherein
R 15 denotes phenyl which is optionally substituted up to 3 times by identical or different fluorine, chlorine, bromine or hydroxyl substituents or by straight-chain or branched alkyl having up to 4 carbon atoms,
or straight-chain or branched alkyl or alkenyl each having up to 20 carbon atoms, each of which is optionally substituted by a group of the formula —OR 16 ,
wherein
R 6 is hydrogen, benzyl, triphenylmethyl or straight-chain or branched acyl having up to 5 carbon atoms,
R 7 represents hydrogen or
R 6 and R 7 together represent the group of the formula ═O,
if appropriate in an isomeric form, and their salts.
3 . Cycloalkano-indole and -azaindole derivatives of the formula according to claim 1
wherein
R 1 and R 2 , including the double bond connecting them, together form a phenyl or pyridyl ring or a ring of the formula
wherein R 8 denotes hydrogen or methyl,
R 3 and R 4 , including the double bond connecting them, together form a phenyl ring or a cyclopentene, cyclohexene, cycloheptene, cyclooctene, oxocyclopentene, oxocyclohexene, oxocycloheptene or oxocyclooctene radical,
or ring systems mentioned under R 1 /R 2 and R 3 /R 4 optionally being substituted up to 2 times by identical or different fluorine, chlorine, bromine, trifluoromethyl, carboxyl or hydroxyl substituents, by straight-chain or branched alkoxy or alkoxycarbonyl each having up to 3 carbon atoms or by straight-chain or branched alkyl having up to 3 carbon atoms, which, for its part, can be substituted by hydroxyl, methoxy or ethoxy,
D represents hydrogen, cyclopentyl, cyclohexyl, cycloheptyl, cyclooctyl or straight-chain or branched alkyl having up to 6 carbon atoms,
E represents the —CO— or —CS— group,
L represents an oxygen or sulphur atom or represents a group of the formula —NR 9 ,
wherein
R 9 denotes hydrogen or straight-chain or branched alkyl having up to 4 carbon atoms, which is optionally substituted by hydroxyl or phenyl,
R 5 represents phenyl, pyridyl or thienyl, each of which is optionally substituted up to 2 times by identical or different nitro, carboxyl, fluorine, chlorine, bromine or cyano substituents, by straight-chain or branched alkenyl or alkoxycarbonyl each having up to 3 carbon atoms or by straight-chain or branched alkyl having up to 4 carbon atoms, which is optionally substituted by hydroxyl, carboxyl or by straight-chain or branched alkoxy or alkoxycarbonyl each having up to 4 carbon atoms,
and/or the cycles are optionally substituted by a group of the formula —OR 10 or —NR 11 R 12 ,
wherein
R 10 denotes hydrogen or straight-chain or branched alkyl or alkenyl each having up to 3 carbon atoms,
R 11 and R 12 are identical or different and denote phenyl, hydrogen or straight-chain or branched alkyl having up to 4 carbon atoms or denote straight-chain or branched acyl having up to 5 carbon atoms, which is optionally substituted by a group of the formula —NR 13 R 14 ,
wherein
R 13 and R 14 are identical or different and denote hydrogen or straight-chain or branched acyl having up to 5 carbon atoms,
R 6 represents hydrogen, carboxyl or straight-chain or branched alkoxycarbonyl having up to 3 carbon atoms, or represents straight-chain or branched alkyl having up to 4 carbon atoms, which is optionally substituted by hydroxyl or by a group of the formula —O—CO—R 15 ,
wherein
R 15 denotes phenyl which is optionally substituted up to 3 times by identical or different straight-chain or branched alkyl having up to 3 carbon atoms,
or denotes straight-chain or branched alkyl or alkenyl each having up to 19 carbon atoms, each of which is optionally substituted by a group of the formula —OR 16 ,
wherein
R 16 denotes hydrogen, benzyl, triphenylmethyl or straight-chain or branched acyl having up to 4 carbon atoms,
R 7 represents hydrogen or
R 6 and R 7 together represent the group of the formula ═O,
if appropriate in an isomeric form, and their salts.
4 . Cycloalkano-indole and -azaindole derivatives according to claim 1 wherein such compound is 2-[4-(2,4-dimethyl-5,6,7,8-tetrahydro-α-carboline-9-yl) methyl-phenyl]-2-cyclopenthyl-acetic acid N-[(R)-phenylglycinolamide] of a formula
in form of their isomeres their recamic mixtures and salts thereof.
5 . Cycloalkano-indole and -azaindole derivatives according to claim 1 wherein such compound is 2-[4-(2,4-dimethyl-α-carboline-9-yl)methyl-phenyl]-2-cyclopenthyl-acetic acid N-[(R)-phenylglucynolamide] of the formula
in form of their enanciomeres their racemates and salts thereof.
6 . Cycloalkano-indole and -azaindole derivatives according to claim 1 wherein such compound is 1-(R,S)-1-Phenyl)-2-triphenylmethyloxy-ethyl[2-(R,S)-2-[4-(2,4-dimethyl-α-carbolin-9-yl)-methyl-phenyl]-2-cyclopentyl-acetate of the formula
in form of their isomeres, their racemates and salts thereof.
7 . Cycloalkano-indoles and -azaindoles according to claim 1 wherein such compound is 2-(R,S)-2-[4-(2,4-Dimethyl-α-carbolin-9-yl)-methyl-phenyl]-2-cyclopentyl-acetic acid [N-(1-(R,S)-1-phenyl-1 carboxy-methyl]-amide of the formula
in form of their isomeres, their racemates and salts thereof.
8 . A composition for the treatment of ateroscleroses comprising an amount effective therefor of a compound or salt thereof according to claim 1 and a pharmacologically ecaptable diluent.
9 . The method of treating ateroscleroses in a pationt in need thereof which comprises atministering to such patient an amount effective therefor of a compound or salt thereof according to claim 1 .Cited by (0)
No later patents cite this yet.
References (0)
No backward citations on record.